AMIA BOLIN: Open Payments
NPI 1770042400 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 10 payments from 7 companies in 2025. Trend: 2023 $728 · 2024 $7,093 · 2025 $621
Food & beverage: $456Consulting: $165
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 2 | $325 |
| Ardelyx, Inc. | 1 | $122 |
| GENZYME CORPORATION | 2 | $70 |
| ABBVIE INC. | 2 | $39 |
| ORPHALAN INC | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: IBSRELA, DUPIXENT, RINVOQ, CUVRIOR, VOQUEZNA, TREMFYA.
Industry payments across AL — which companies pay providers there.
